EP2630498A4 - PROGNOSTIC BIOMARKERS IN PATIENTS WITH OVARIAN CANCER - Google Patents
PROGNOSTIC BIOMARKERS IN PATIENTS WITH OVARIAN CANCERInfo
- Publication number
- EP2630498A4 EP2630498A4 EP11835211.1A EP11835211A EP2630498A4 EP 2630498 A4 EP2630498 A4 EP 2630498A4 EP 11835211 A EP11835211 A EP 11835211A EP 2630498 A4 EP2630498 A4 EP 2630498A4
- Authority
- EP
- European Patent Office
- Prior art keywords
- patients
- ovarian cancer
- prognostic biomarkers
- prognostic
- biomarkers
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57407—Specifically defined cancers
- G01N33/57449—Specifically defined cancers of ovaries
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
- G01N30/88—Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86
- G01N2030/8809—Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86 analysis specially adapted for the sample
- G01N2030/8813—Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86 analysis specially adapted for the sample biological materials
- G01N2030/8831—Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86 analysis specially adapted for the sample biological materials involving peptides or proteins
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N27/00—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means
- G01N27/26—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means by investigating electrochemical variables; by using electrolysis or electrophoresis
- G01N27/416—Systems
- G01N27/447—Systems using electrophoresis
- G01N27/44756—Apparatus specially adapted therefor
- G01N27/44773—Multi-stage electrophoresis, e.g. two-dimensional electrophoresis
- G01N27/44778—Multi-stage electrophoresis, e.g. two-dimensional electrophoresis on a common gel carrier, i.e. 2D gel electrophoresis
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/54—Determining the risk of relapse
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/56—Staging of a disease; Further complications associated with the disease
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- Cell Biology (AREA)
- Hospice & Palliative Care (AREA)
- Biotechnology (AREA)
- Food Science & Technology (AREA)
- Oncology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Microbiology (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US40604410P | 2010-10-22 | 2010-10-22 | |
PCT/US2011/057271 WO2012054824A2 (en) | 2010-10-22 | 2011-10-21 | Prognostic biomarkers in patients with ovarian cancer |
Publications (2)
Publication Number | Publication Date |
---|---|
EP2630498A2 EP2630498A2 (en) | 2013-08-28 |
EP2630498A4 true EP2630498A4 (en) | 2014-10-01 |
Family
ID=45975910
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP11835211.1A Ceased EP2630498A4 (en) | 2010-10-22 | 2011-10-21 | PROGNOSTIC BIOMARKERS IN PATIENTS WITH OVARIAN CANCER |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP2630498A4 (ja) |
JP (2) | JP2013541716A (ja) |
AU (1) | AU2011316844A1 (ja) |
CA (1) | CA2818593A1 (ja) |
WO (1) | WO2012054824A2 (ja) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP4286853A3 (en) * | 2013-05-10 | 2024-03-06 | Johns Hopkins University | Compositions for ovarian cancer assessment having improved specificity |
RU2678108C2 (ru) * | 2014-04-23 | 2019-01-23 | Нитирей Байосайенсиз Инк. | Комбинированный продукт для детекции маркера-мишени |
EP3435379A1 (en) * | 2017-07-27 | 2019-01-30 | Roche Diagnostics GmbH | Augmenting measurement values of biological samples |
KR102082462B1 (ko) * | 2017-10-31 | 2020-02-27 | 국립암센터 | nc886 유전자를 이용한 난소암 예후 예측을 위한 정보제공방법 |
JP7272627B2 (ja) * | 2019-01-24 | 2023-05-12 | 公立大学法人和歌山県立医科大学 | 卵巣腫瘍の評価用バイオマーカー |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2008048508A2 (en) * | 2006-10-13 | 2008-04-24 | Vermillion, Inc. | Prognostic biomarkers in patients with ovarian cancer |
WO2009058331A2 (en) * | 2007-10-29 | 2009-05-07 | Vermilllion, Inc. | Biomarkers for the detection of early stage ovarian cancer |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7605003B2 (en) * | 2002-08-06 | 2009-10-20 | The Johns Hopkins University | Use of biomarkers for detecting ovarian cancer |
WO2006019906A1 (en) * | 2004-07-14 | 2006-02-23 | The Regents Of The University Of California | Biomarker for early detection of ovarian cancer |
CA2602088C (en) * | 2005-03-11 | 2021-07-27 | Ciphergen Biosystems, Inc. | Biomarkers for ovarian cancer and endometrial cancer |
US20100197561A1 (en) * | 2005-06-24 | 2010-08-05 | Ciphergen Biosystems, Inc. | Biomarkers for Ovarian Cancer: B2 Microglobulin |
WO2008060376A2 (en) * | 2006-10-04 | 2008-05-22 | The Johns Hopkins University | Algorithims for multivariant models to combine a panel of biomarkers for assessing the risk of developing ovarian cancer |
WO2009006439A1 (en) * | 2007-06-29 | 2009-01-08 | Correlogic Systems, Inc. | Predictive markers for ovarian cancer |
JP5391400B2 (ja) * | 2007-10-01 | 2014-01-15 | 公益財団法人ヒューマンサイエンス振興財団 | α−アクチニン−4遺伝子のコピー数または発現レベルを指標とした膵癌の検出を補助する方法および診断のためのキット |
AU2009339802B2 (en) * | 2009-02-16 | 2014-07-24 | Atlas Antibodies Ab | RBM3 as a marker for malignant melanoma prognosis |
-
2011
- 2011-10-21 CA CA2818593A patent/CA2818593A1/en not_active Abandoned
- 2011-10-21 WO PCT/US2011/057271 patent/WO2012054824A2/en active Application Filing
- 2011-10-21 EP EP11835211.1A patent/EP2630498A4/en not_active Ceased
- 2011-10-21 AU AU2011316844A patent/AU2011316844A1/en not_active Abandoned
- 2011-10-21 JP JP2013535113A patent/JP2013541716A/ja active Pending
-
2016
- 2016-08-04 JP JP2016153332A patent/JP2016212116A/ja active Pending
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2008048508A2 (en) * | 2006-10-13 | 2008-04-24 | Vermillion, Inc. | Prognostic biomarkers in patients with ovarian cancer |
WO2009058331A2 (en) * | 2007-10-29 | 2009-05-07 | Vermilllion, Inc. | Biomarkers for the detection of early stage ovarian cancer |
Also Published As
Publication number | Publication date |
---|---|
EP2630498A2 (en) | 2013-08-28 |
CA2818593A1 (en) | 2012-04-26 |
JP2013541716A (ja) | 2013-11-14 |
AU2011316844A1 (en) | 2013-06-06 |
WO2012054824A3 (en) | 2012-07-19 |
WO2012054824A2 (en) | 2012-04-26 |
JP2016212116A (ja) | 2016-12-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL252163A0 (en) | Lung cancer biomarkers and their uses | |
EP2536854A4 (en) | CUSTOMIZED TUMOR BIOMARKERS | |
IL223295A0 (en) | Lung cancer biomarkers and uses thereof | |
EP2382331A4 (en) | KREBSBIOMARKER | |
SG2014007454A (en) | Pancreatic cancer biomarkers and uses thereof | |
EP2825674A4 (en) | BIOMARKER FOR THYROID CANCER | |
EP2776832A4 (en) | BIOMARKER FOR BUBBLE CANCER AND METHOD FOR ITS USE | |
HK1206414A1 (en) | Biomarkers for gastric cancer and uses thereof | |
EP2625292A4 (en) | KREBSBIOMARKER | |
HK1181846A1 (zh) | 新的卵巢癌生物標誌物和靶 | |
GB2513275B (en) | Biomarkers for Breast Cancer Prediction and Diagnosis | |
EP2931922A4 (en) | PERSONALIZED BIOMARKERS FOR CANCER | |
GB2513771B (en) | Biomarkers for breast cancer predictions and diagnoses | |
GB201021502D0 (en) | Biomarkers | |
EP3090065A4 (en) | Methods for measuring biomarkers in gastrointestinal cancer | |
GB201008340D0 (en) | Biomarkers | |
EP2600896A4 (en) | TREATMENT OF BREAST CANCER WITH ANTI-IL-19 ANTIBODIES | |
GB201018056D0 (en) | Biomarkers | |
EP2630498A4 (en) | PROGNOSTIC BIOMARKERS IN PATIENTS WITH OVARIAN CANCER | |
GB201005561D0 (en) | Biomarkers | |
GB201001444D0 (en) | Biomarkers | |
EP2350917A4 (en) | BIOMARKERS OF OVARIAN CANCER AND USES THEREOF | |
EP2554994A4 (en) | BIOMARKERS | |
GB201005456D0 (en) | Biomarkers | |
GB201010316D0 (en) | Biomarkers |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 20130521 |
|
AK | Designated contracting states |
Kind code of ref document: A2 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
DAX | Request for extension of the european patent (deleted) | ||
A4 | Supplementary search report drawn up and despatched |
Effective date: 20140901 |
|
RIC1 | Information provided on ipc code assigned before grant |
Ipc: G01N 33/543 20060101ALI20140826BHEP Ipc: G01N 33/574 20060101AFI20140826BHEP Ipc: G01N 30/00 20060101ALI20140826BHEP Ipc: G01N 33/68 20060101ALI20140826BHEP |
|
17Q | First examination report despatched |
Effective date: 20150904 |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R003 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION HAS BEEN REFUSED |
|
18R | Application refused |
Effective date: 20161104 |